These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of methyldopa metabolites on amine transmitters and adrenergic receptors in rat brain. Louis WJ, Conway E, Summers R, Beart P, Jarrott B. Hypertension; 1984; 6(5 Pt 2):II40-4. PubMed ID: 6094348 [Abstract] [Full Text] [Related]
3. Central and peripheral cardiovascular effects of alpha-methylepinephrine. Tung CS, Goldberg MR, Hollister AS, Oates JA, Robertson D. J Pharmacol Exp Ther; 1983 Nov; 227(2):484-90. PubMed ID: 6355433 [Abstract] [Full Text] [Related]
8. Changes in brain alpha-adrenergic receptors after alpha-methyldopa administration to spontaneously hypertensive rats. Freed CR, Wang CH, U'Prichard DC. Hypertension; 1984 Jun; 6(5 Pt 2):II34-9. PubMed ID: 6094347 [Abstract] [Full Text] [Related]
9. Limitation of the alpha-methylnorepinephrine hypothesis in the hypotensive effect of alpha-methyldopa. Tung CS, Chen SZ, Hsu CH, Tseng CJ. Clin Exp Hypertens A; 1989 Jun; 11(1):45-58. PubMed ID: 2653670 [Abstract] [Full Text] [Related]
10. Pharmacological effects of alpha-methyldopa, alpha-methylnorepinephrine, and octopamine on rat arteriolar, arterial, and terminal vascular smooth. Altura BM. Circ Res; 1975 Jun; 36(6 Suppl 1):233-40. PubMed ID: 1093755 [Abstract] [Full Text] [Related]
11. alpha-methyldopa reduces locomotor activity in rats via its metabolite, alpha-methylnorepinephrine, acting on alpha 2-adrenoceptors. Clineschmidt BV, Flataker LM, Faison EP, Haubrich DR. Arch Int Pharmacodyn Ther; 1980 Apr; 244(2):231-43. PubMed ID: 6250499 [Abstract] [Full Text] [Related]
12. alpha-Methyldopa, alpha-methyldopamine an alpha-methylnoradrenaline: substrates for the thermolabile form of human platelet phenol sulphotransferase. Mwaluko G, Weinshilboum R. Br J Clin Pharmacol; 1982 Aug; 14(2):231-9. PubMed ID: 7049213 [Abstract] [Full Text] [Related]
17. In summary: satellite symposium on central alpha-adrenergic blood pressure regulating mechanisms. Abrams WB. Hypertension; 1984 Mar; 6(5 Pt 2):II87-93. PubMed ID: 6150004 [Abstract] [Full Text] [Related]
18. The neurochemical and stimulatory effects of putative metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in rats. Yeh SY, Hsu FL. Pharmacol Biochem Behav; 1991 Jul; 39(3):787-90. PubMed ID: 1723801 [Abstract] [Full Text] [Related]
19. Stereochemical course in vivo of alpha-methyldopa decarboxylation in rat brains. Ames MM, Melmon KL, Castagnoli N. Biochem Pharmacol; 1977 Oct 01; 26(19):1757-62. PubMed ID: 334182 [No Abstract] [Full Text] [Related]
20. Studies on the hypotensive action of alpha-methyldopamine. Finch L, Hersom A, Hicks P. Br J Pharmacol; 1975 Aug 01; 54(4):445-51. PubMed ID: 1100157 [Abstract] [Full Text] [Related] Page: [Next] [New Search]